AJJ Medtech Holdings (SGX:584) Other Current Receivables: S$0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is AJJ Medtech Holdings Other Current Receivables?

AJJ Medtech Holdings SGX:584 +33.33% Other Current Receivables is S$0.00 Mil as of Jun. 2026. The stock has 4 warning signs investors should review.

AJJ Medtech Holdings's Other Current Receivables for the quarter that ended in Jun. 2026 was S$0.00 Mil.

AJJ Medtech Holdings's quarterly Other Current Receivables declined from Dec. 2025 (S$0.07 Mil) to Mar. 2026 (S$0.00 Mil) but then stayed the same from Mar. 2026 (S$0.00 Mil) to Jun. 2026 (S$0.00 Mil).

AJJ Medtech Holdings's annual Other Current Receivables declined from Dec. 2023 (S$0.11 Mil) to Dec. 2024 (S$0.11 Mil) and declined from Dec. 2024 (S$0.11 Mil) to Dec. 2025 (S$0.07 Mil).

AJJ Medtech Holdings Other Current Receivables Related Terms

AJJ Medtech Holdings Other Current Receivables Historical Data

* Premium members only.

The historical data trend for AJJ Medtech Holdings's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AJJ Medtech Holdings Other Current Receivables Chart

AJJ Medtech Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.06 0.11 0.11 0.07

AJJ Medtech Holdings Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.07 0.00 0.00

AJJ Medtech Holdings Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of S$0.00 Mil mean?
AJJ Medtech Holdings (SGX:584) has a Other Current Receivables of S$0.00 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on AJJ Medtech Holdings and its competitors.
Is AJJ Medtech Holdings' Other Current Receivables too high?
AJJ Medtech Holdings' current Other Current Receivables is S$0.00 Mil.
How does AJJ Medtech Holdings' Other Current Receivables compare to ABT and SYK?
AJJ Medtech Holdings' Other Current Receivables of S$0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on AJJ Medtech Holdings and its competitors. AJJ Medtech Holdings's current Other Current Receivables is S$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AJJ Medtech Holdings stock overvalued right now?
AJJ Medtech Holdings (SGX:584) has a current Other Current Receivables of S$0.00 Mil. The current Other Current Receivables is S$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For AJJ Medtech Holdings (SGX:584), the current Other Current Receivables is S$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AJJ Medtech Holdings Business Description

Address 8 Commonwealth Lane, No. 02-04, Grande Building, Singapore, SGP, 149555
AJJ Medtech Holdings Ltd is a healthcare technology company building an integrated platform across medical devices, digital systems, and intelligent care infrastructure in Singapore, Southeast Asia, and selected international markets. It integrates artificial intelligence, robotics, and healthcare systems to support healthcare delivery across the patient care continuum. Its portfolio includes diagnostic systems, medical and dental devices, consumables, digital and robotics-enabled healthcare solutions, and turn-key supply-chain solutions. Its segments are corporate and investment holding, healthcare products and services, and healthcare digital products, which generate maximum revenue. It operates mainly in Singapore, and its revenue is derived from the sale of medical healthcare products.